/URT.WA
URT.WA Stock - Urteste S.A.
Healthcare|BiotechnologyWSE
$40.00+7.53%
+$2.80 (+7.53%) • Dec 23
65
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.40
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $44.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for URT.WA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$39.60 – $40.40
TARGET (TP)$46.00
STOP LOSS$36.80
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.34
52W High$106.00
52W Low$24.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.80M | $1.33M | $3,000 | N/A | N/A |
| Gross Profit | $1.50M | $-479,000 | $-288,000 | $-116,609 | $-14,841 |
| Gross Margin | 83.4% | -36.0% | -9600.0% | N/A | N/A |
| Operating Income | $-4,174,000 | $-6,447,000 | $-4,130,000 | $-4,187,000 | $-1,222,000 |
| Net Income | $-3,631,000 | $-5,586,000 | $-4,060,000 | $-2,321,802 | $-530,223 |
| Net Margin | -201.7% | -420.0% | -135333.3% | N/A | N/A |
| EPS | $-2.58 | $-4.32 | $-3.58 | $-2.21 | $-2.05 |
Company Overview
Urteste S.A. engages in the research and development of diagnostic tests for cancers. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, stomach, lung, oesophagus, ovary, endometrium, blood, breast, and nervous system cancer. The company was incorporated in 2021 and is based in Gdansk, Poland.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
URT.WALoading earnings data...
Latest News
Loading news...
Frequently Asked Questions about URT.WA
What is URT.WA's current stock price?
Urteste S.A. (URT.WA) is currently trading at $40.00 per share. The stock has moved +7.53% today.
What is the analyst price target for URT.WA?
No analyst price targets are currently available for this stock.
What sector is Urteste S.A. in?
Urteste S.A. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the WSE exchange.
What is URT.WA's market cap?
Urteste S.A. has a market capitalization of $0.06 billion, making it a small-cap company.
Does URT.WA pay dividends?
No, Urteste S.A. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorADV.WA
Adiuvo Investments S.A.
$0.50
Mkt Cap: $0.0B
AWM.WA
Airway Medix S.A.
$0.33
Mkt Cap: $0.0B
BMX.WA
BioMaxima S.A.
$11.10
Mkt Cap: $0.0B
GMT.WA
Genomtec S.A.
$3.77
Mkt Cap: $0.1B
MAB.WA
Mabion S.A.
$6.95
Mkt Cap: $0.1B
MOC.WA
Molecure S.A.
$6.36
Mkt Cap: $0.1B
NNG.WA
NanoGroup S.A.
$2.60
Mkt Cap: $0.1B
PHR.WA
Pharmena S.A.
$2.55
Mkt Cap: $0.0B
PTG.WA
Poltreg S.A.
$24.60
Mkt Cap: $0.1B
PUR.WA
Pure Biologics Spólka Akcyjna
$3.70
Mkt Cap: $0.0B
Explore stocks similar to URT.WA for comparison